We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDE icon
3051
Coeur Mining
CDE
$15.4B
$217K ﹤0.01%
+48,737
New +$232K
INVZ icon
3052
Innoviz Technologies
INVZ
$99.5M
$217K ﹤0.01%
60,195
-3,801
-6% -$15.2K
SMP icon
3053
Standard Motor Products
SMP
$897M
$217K ﹤0.01%
5,023
-19,844
-80% -$930K
PHX
3054
DELISTED
PHX Minerals
PHX
$216K ﹤0.01%
70,689
-24,894
-26% -$63.4K
BIOC
3055
DELISTED
Biocept, Inc.
BIOC
$215K ﹤0.01%
3,094
-2,114
-41% -$166K
FMX icon
3056
Fomento Económico Mexicano
FMX
$43.5B
$214K ﹤0.01%
2,584
-115,088
-98% -$9.07M
VRRM icon
3057
Verra Mobility
VRRM
$635M
$214K ﹤0.01%
13,138
-38,302
-74% -$616K
SKYAW
3058
CALL
DELISTED
Skydeck Acquisition Corp. Warrants
SKYAW
$214K ﹤0.01%
21,933
GOCO
3059
DELISTED
GoHealth
GOCO
$213K ﹤0.01%
+12,042
New +$375K
TPG icon
3060
TPG
TPG
$7.02B
$213K ﹤0.01%
+7,064
New +$218K
CSCO icon
3061
Cisco
CSCO
$456B
$212K ﹤0.01%
3,806
-531,902
-99% -$30.1M
MLR icon
3062
Miller Industries
MLR
$584M
$212K ﹤0.01%
+7,551
New +$233K
URNM icon
3063
Sprott Uranium Miners ETF
URNM
$1.75B
$212K ﹤0.01%
+5,106
New +$188K
ASAI
3064
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$212K ﹤0.01%
12,387
-19,691
-61% -$248K
MCHB
3065
Mechanics Bancorp
MCHB
$3.51B
$211K ﹤0.01%
+4,458
New +$228K
LNT icon
3066
Alliant Energy
LNT
$19.1B
$211K ﹤0.01%
3,374
-4,596
-58% -$273K
NSLR
3067
Neostellar Capital Corp
NSLR
$269M
$211K ﹤0.01%
24,535
-411,749
-94% -$4.61M
VET icon
3068
Vermilion Energy
VET
$1.59B
$211K ﹤0.01%
10,012
-69,627
-87% -$1.24M
SPIR.WS
3069
CALL
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
$209K ﹤0.01%
100,000
CVM icon
3070
CEL-SCI Corp
CVM
$21M
$208K ﹤0.01%
1,756
-3,400
-66% -$553K
COOK icon
3071
Traeger
COOK
$164M
$206K ﹤0.01%
+554
New +$264K
ECOR icon
3072
electroCore
ECOR
$50.5M
$206K ﹤0.01%
23,591
-9,059
-28% -$82.2K
PTPI
3073
DELISTED
Petros Pharmaceuticals
PTPI
$205K ﹤0.01%
525
-451
-46% -$190K
TGLS icon
3074
Tecnoglass
TGLS
$2.09B
$205K ﹤0.01%
+8,138
New +$183K
BF.B icon
3075
Brown-Forman Class B
BF.B
$13.3B
$204K ﹤0.01%
+3,051
New +$203K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.